US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 1.620
  • -0.040-2.41%
Close Dec 26 16:00 ET
  • 1.640
  • +0.020+1.23%
Post 19:59 ET
184.51MMarket Cap-0.99P/E (TTM)

Fate Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-15.10%296.92M
-19.33%304.88M
-6.20%383.54M
-27.75%315.18M
-27.75%315.18M
-30.76%349.73M
-33.56%377.94M
-28.74%408.9M
-29.17%436.23M
-29.17%436.23M
-Cash and cash equivalents
13.72%37.91M
-21.12%36.92M
188.72%121.32M
-31.73%41.87M
-31.73%41.87M
-59.39%33.33M
-15.33%46.8M
-35.10%42.02M
-54.09%61.33M
-54.09%61.33M
-Short-term investments
-18.14%259.01M
-19.08%267.96M
-28.53%262.22M
-27.10%273.31M
-27.10%273.31M
-25.21%316.4M
-35.52%331.13M
-27.93%366.88M
-22.27%374.89M
-22.27%374.89M
Receivables
168.34%4.13M
-63.01%1.05M
-93.64%858K
-95.25%1.83M
-95.25%1.83M
-84.96%1.54M
-78.42%2.83M
-2.53%13.5M
343.52%38.48M
343.52%38.48M
-Accounts receivable
168.34%4.13M
-63.01%1.05M
-93.64%858K
-95.25%1.83M
-95.25%1.83M
-84.96%1.54M
-78.42%2.83M
-2.53%13.5M
343.52%38.48M
343.52%38.48M
Other current assets
-28.35%9.24M
17.93%13.46M
-35.62%9.97M
-46.87%14.54M
-46.87%14.54M
--12.9M
--11.41M
--15.49M
210.07%27.37M
210.07%27.37M
Total current assets
-14.80%310.29M
-18.56%319.39M
-9.94%394.38M
-33.97%331.54M
-33.97%331.54M
-31.97%364.17M
-34.54%392.18M
-26.91%437.89M
-20.74%502.07M
-20.74%502.07M
Non current assets
Net PPE
-14.35%140.83M
-13.52%147.08M
-11.85%152.74M
-9.98%158.51M
-9.98%158.51M
-6.84%164.43M
-0.89%170.07M
3.55%173.28M
8.53%176.09M
8.53%176.09M
-Gross PPE
-14.35%140.83M
-13.52%147.08M
-11.85%152.74M
-0.16%206.14M
-0.16%206.14M
-6.84%164.43M
-0.89%170.07M
3.55%173.28M
15.22%206.47M
15.22%206.47M
-Accumulated depreciation
----
----
----
-56.75%-47.63M
-56.75%-47.63M
----
----
----
-79.31%-30.38M
-79.31%-30.38M
Investments and advances
--33.61M
546.85%47.16M
94.15%7.6M
-80.17%980K
-80.17%980K
--0
-38.86%7.29M
-94.24%3.91M
-95.09%4.94M
-95.09%4.94M
Non current accounts receivable
----
----
----
----
----
----
----
----
-27.09%7.2M
-27.09%7.2M
Other non current assets
-32.60%10.24M
-0.16%15.19M
-0.48%15.19M
-0.48%15.19M
-0.48%15.19M
-0.48%15.19M
-0.33%15.21M
0.00%15.26M
0.00%15.26M
0.00%15.26M
Total non current assets
2.82%184.68M
8.75%209.43M
-8.80%175.52M
-14.16%174.68M
-14.16%174.68M
-16.08%179.61M
-7.37%192.58M
-25.78%192.45M
-29.36%203.49M
-29.36%203.49M
Total assets
-8.98%494.97M
-9.57%528.82M
-9.59%569.89M
-28.25%506.22M
-28.25%506.22M
-27.43%543.79M
-27.54%584.76M
-26.57%630.34M
-23.43%705.56M
-23.43%705.56M
Liabilities
Current liabilities
Payables
11.27%6.35M
-26.79%5.5M
-31.35%6.77M
-42.90%4.72M
-42.90%4.72M
-40.52%5.71M
-10.86%7.51M
-13.89%9.86M
-4.03%8.27M
-4.03%8.27M
-accounts payable
11.27%6.35M
-26.79%5.5M
-31.35%6.77M
-42.90%4.72M
-42.90%4.72M
-40.52%5.71M
-10.86%7.51M
-13.89%9.86M
-4.03%8.27M
-4.03%8.27M
Current accrued expenses
-17.38%23.58M
-23.13%22.65M
1.68%32.04M
-48.98%27.51M
-48.98%27.51M
-43.09%28.54M
-27.28%29.47M
-10.24%31.51M
27.16%53.93M
27.16%53.93M
Current debt and capital lease obligation
15.33%6.89M
14.83%6.64M
15.46%6.4M
9.74%6.18M
9.74%6.18M
3.86%5.98M
1.21%5.79M
-0.66%5.55M
0.91%5.63M
0.91%5.63M
-Current capital lease obligation
15.33%6.89M
14.83%6.64M
15.46%6.4M
9.74%6.18M
9.74%6.18M
3.86%5.98M
1.21%5.79M
-0.66%5.55M
0.91%5.63M
0.91%5.63M
Current deferred liabilities
-45.95%600K
--0
-90.85%159K
-98.38%685K
-98.38%685K
-96.85%1.11M
-94.27%1.93M
-92.30%1.74M
96.56%42.23M
96.56%42.23M
Other current liabilities
----
----
----
----
----
----
----
----
25.00%4M
25.00%4M
Current liabilities
-9.46%37.42M
-22.15%34.79M
-6.75%45.37M
-65.72%39.09M
-65.72%39.09M
-60.23%41.33M
-51.17%44.69M
-37.56%48.65M
40.31%114.05M
40.31%114.05M
Non current liabilities
Long term debt and capital lease obligation
-6.96%92.09M
-6.61%93.92M
-6.27%95.67M
-6.12%97.36M
-6.12%97.36M
-5.88%98.98M
-5.65%100.56M
-5.44%102.07M
-5.06%103.71M
-5.06%103.71M
-Long term capital lease obligation
-6.96%92.09M
-6.61%93.92M
-6.27%95.67M
-6.12%97.36M
-6.12%97.36M
-5.88%98.98M
-5.65%100.56M
-5.44%102.07M
-5.06%103.71M
-5.06%103.71M
Derivative product liabilities
70.76%1.2M
-32.34%1.18M
27.86%2.74M
-65.14%1.35M
-65.14%1.35M
-92.24%701K
-82.37%1.75M
-86.44%2.14M
-84.02%3.86M
-84.02%3.86M
Other non current liabilities
--1.94M
--1.94M
----
----
----
----
----
----
----
----
Total non current liabilities
-4.47%95.22M
-5.15%97.04M
-5.57%98.41M
-8.24%98.71M
-8.24%98.71M
-21.76%99.68M
-24.25%102.31M
-29.15%104.21M
-33.32%107.57M
-33.32%107.57M
Total liabilities
-5.93%132.64M
-10.32%131.84M
-5.94%143.78M
-37.82%137.8M
-37.82%137.8M
-39.05%141.01M
-35.12%147M
-32.06%152.86M
-8.65%221.62M
-8.65%221.62M
Shareholders'equity
Share capital
14.71%117K
14.71%117K
15.84%117K
2.00%102K
2.00%102K
2.00%102K
2.00%102K
1.00%101K
1.01%100K
1.01%100K
-common stock
15.15%114K
15.15%114K
16.33%114K
2.06%99K
2.06%99K
2.06%99K
2.06%99K
1.03%98K
1.04%97K
1.04%97K
-Preferred stock
0.00%3K
0.00%3K
0.00%3K
0.00%3K
0.00%3K
0.00%3K
0.00%3K
0.00%3K
0.00%3K
0.00%3K
Retained earnings
-15.26%-1.35B
-15.66%-1.3B
-17.77%-1.26B
-15.31%-1.21B
-15.31%-1.21B
-17.41%-1.17B
-23.23%-1.12B
-28.14%-1.07B
-36.63%-1.05B
-36.63%-1.05B
Paid-in capital
8.69%1.71B
8.64%1.7B
8.93%1.69B
2.83%1.58B
2.83%1.58B
3.64%1.57B
4.42%1.56B
5.22%1.55B
6.07%1.54B
6.07%1.54B
Gains losses not affecting retained earnings
267.33%835K
28.11%-422K
69.97%-194K
100.81%15K
100.81%15K
84.66%-499K
82.64%-587K
77.33%-646K
-143.31%-1.85M
-143.31%-1.85M
Total stockholders'equity
-10.04%362.33M
-9.31%396.98M
-10.76%426.12M
-23.87%368.42M
-23.87%368.42M
-22.24%402.78M
-24.59%437.76M
-24.62%477.47M
-28.71%483.94M
-28.71%483.94M
Total equity
-10.04%362.33M
-9.31%396.98M
-10.76%426.12M
-23.87%368.42M
-23.87%368.42M
-22.24%402.78M
-24.59%437.76M
-24.62%477.47M
-28.71%483.94M
-28.71%483.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -15.10%296.92M-19.33%304.88M-6.20%383.54M-27.75%315.18M-27.75%315.18M-30.76%349.73M-33.56%377.94M-28.74%408.9M-29.17%436.23M-29.17%436.23M
-Cash and cash equivalents 13.72%37.91M-21.12%36.92M188.72%121.32M-31.73%41.87M-31.73%41.87M-59.39%33.33M-15.33%46.8M-35.10%42.02M-54.09%61.33M-54.09%61.33M
-Short-term investments -18.14%259.01M-19.08%267.96M-28.53%262.22M-27.10%273.31M-27.10%273.31M-25.21%316.4M-35.52%331.13M-27.93%366.88M-22.27%374.89M-22.27%374.89M
Receivables 168.34%4.13M-63.01%1.05M-93.64%858K-95.25%1.83M-95.25%1.83M-84.96%1.54M-78.42%2.83M-2.53%13.5M343.52%38.48M343.52%38.48M
-Accounts receivable 168.34%4.13M-63.01%1.05M-93.64%858K-95.25%1.83M-95.25%1.83M-84.96%1.54M-78.42%2.83M-2.53%13.5M343.52%38.48M343.52%38.48M
Other current assets -28.35%9.24M17.93%13.46M-35.62%9.97M-46.87%14.54M-46.87%14.54M--12.9M--11.41M--15.49M210.07%27.37M210.07%27.37M
Total current assets -14.80%310.29M-18.56%319.39M-9.94%394.38M-33.97%331.54M-33.97%331.54M-31.97%364.17M-34.54%392.18M-26.91%437.89M-20.74%502.07M-20.74%502.07M
Non current assets
Net PPE -14.35%140.83M-13.52%147.08M-11.85%152.74M-9.98%158.51M-9.98%158.51M-6.84%164.43M-0.89%170.07M3.55%173.28M8.53%176.09M8.53%176.09M
-Gross PPE -14.35%140.83M-13.52%147.08M-11.85%152.74M-0.16%206.14M-0.16%206.14M-6.84%164.43M-0.89%170.07M3.55%173.28M15.22%206.47M15.22%206.47M
-Accumulated depreciation -------------56.75%-47.63M-56.75%-47.63M-------------79.31%-30.38M-79.31%-30.38M
Investments and advances --33.61M546.85%47.16M94.15%7.6M-80.17%980K-80.17%980K--0-38.86%7.29M-94.24%3.91M-95.09%4.94M-95.09%4.94M
Non current accounts receivable ---------------------------------27.09%7.2M-27.09%7.2M
Other non current assets -32.60%10.24M-0.16%15.19M-0.48%15.19M-0.48%15.19M-0.48%15.19M-0.48%15.19M-0.33%15.21M0.00%15.26M0.00%15.26M0.00%15.26M
Total non current assets 2.82%184.68M8.75%209.43M-8.80%175.52M-14.16%174.68M-14.16%174.68M-16.08%179.61M-7.37%192.58M-25.78%192.45M-29.36%203.49M-29.36%203.49M
Total assets -8.98%494.97M-9.57%528.82M-9.59%569.89M-28.25%506.22M-28.25%506.22M-27.43%543.79M-27.54%584.76M-26.57%630.34M-23.43%705.56M-23.43%705.56M
Liabilities
Current liabilities
Payables 11.27%6.35M-26.79%5.5M-31.35%6.77M-42.90%4.72M-42.90%4.72M-40.52%5.71M-10.86%7.51M-13.89%9.86M-4.03%8.27M-4.03%8.27M
-accounts payable 11.27%6.35M-26.79%5.5M-31.35%6.77M-42.90%4.72M-42.90%4.72M-40.52%5.71M-10.86%7.51M-13.89%9.86M-4.03%8.27M-4.03%8.27M
Current accrued expenses -17.38%23.58M-23.13%22.65M1.68%32.04M-48.98%27.51M-48.98%27.51M-43.09%28.54M-27.28%29.47M-10.24%31.51M27.16%53.93M27.16%53.93M
Current debt and capital lease obligation 15.33%6.89M14.83%6.64M15.46%6.4M9.74%6.18M9.74%6.18M3.86%5.98M1.21%5.79M-0.66%5.55M0.91%5.63M0.91%5.63M
-Current capital lease obligation 15.33%6.89M14.83%6.64M15.46%6.4M9.74%6.18M9.74%6.18M3.86%5.98M1.21%5.79M-0.66%5.55M0.91%5.63M0.91%5.63M
Current deferred liabilities -45.95%600K--0-90.85%159K-98.38%685K-98.38%685K-96.85%1.11M-94.27%1.93M-92.30%1.74M96.56%42.23M96.56%42.23M
Other current liabilities --------------------------------25.00%4M25.00%4M
Current liabilities -9.46%37.42M-22.15%34.79M-6.75%45.37M-65.72%39.09M-65.72%39.09M-60.23%41.33M-51.17%44.69M-37.56%48.65M40.31%114.05M40.31%114.05M
Non current liabilities
Long term debt and capital lease obligation -6.96%92.09M-6.61%93.92M-6.27%95.67M-6.12%97.36M-6.12%97.36M-5.88%98.98M-5.65%100.56M-5.44%102.07M-5.06%103.71M-5.06%103.71M
-Long term capital lease obligation -6.96%92.09M-6.61%93.92M-6.27%95.67M-6.12%97.36M-6.12%97.36M-5.88%98.98M-5.65%100.56M-5.44%102.07M-5.06%103.71M-5.06%103.71M
Derivative product liabilities 70.76%1.2M-32.34%1.18M27.86%2.74M-65.14%1.35M-65.14%1.35M-92.24%701K-82.37%1.75M-86.44%2.14M-84.02%3.86M-84.02%3.86M
Other non current liabilities --1.94M--1.94M--------------------------------
Total non current liabilities -4.47%95.22M-5.15%97.04M-5.57%98.41M-8.24%98.71M-8.24%98.71M-21.76%99.68M-24.25%102.31M-29.15%104.21M-33.32%107.57M-33.32%107.57M
Total liabilities -5.93%132.64M-10.32%131.84M-5.94%143.78M-37.82%137.8M-37.82%137.8M-39.05%141.01M-35.12%147M-32.06%152.86M-8.65%221.62M-8.65%221.62M
Shareholders'equity
Share capital 14.71%117K14.71%117K15.84%117K2.00%102K2.00%102K2.00%102K2.00%102K1.00%101K1.01%100K1.01%100K
-common stock 15.15%114K15.15%114K16.33%114K2.06%99K2.06%99K2.06%99K2.06%99K1.03%98K1.04%97K1.04%97K
-Preferred stock 0.00%3K0.00%3K0.00%3K0.00%3K0.00%3K0.00%3K0.00%3K0.00%3K0.00%3K0.00%3K
Retained earnings -15.26%-1.35B-15.66%-1.3B-17.77%-1.26B-15.31%-1.21B-15.31%-1.21B-17.41%-1.17B-23.23%-1.12B-28.14%-1.07B-36.63%-1.05B-36.63%-1.05B
Paid-in capital 8.69%1.71B8.64%1.7B8.93%1.69B2.83%1.58B2.83%1.58B3.64%1.57B4.42%1.56B5.22%1.55B6.07%1.54B6.07%1.54B
Gains losses not affecting retained earnings 267.33%835K28.11%-422K69.97%-194K100.81%15K100.81%15K84.66%-499K82.64%-587K77.33%-646K-143.31%-1.85M-143.31%-1.85M
Total stockholders'equity -10.04%362.33M-9.31%396.98M-10.76%426.12M-23.87%368.42M-23.87%368.42M-22.24%402.78M-24.59%437.76M-24.62%477.47M-28.71%483.94M-28.71%483.94M
Total equity -10.04%362.33M-9.31%396.98M-10.76%426.12M-23.87%368.42M-23.87%368.42M-22.24%402.78M-24.59%437.76M-24.62%477.47M-28.71%483.94M-28.71%483.94M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.